HK Stock Market Move | LYGEND RESOURCE (02245) rose over 6% in late trading. LYGEND RESOURCE officially listed on the Main Board of the Shenzhen Stock Exchange, achieving a dual listing in both A-shares and H-shares.
LYGEND RESOURCE (02245) rose over 6% in late trading. As of press time, it was up 5.88%, at HK$20.0, with a turnover of HK$191 million.
LYGEND RESOURCE (02245) rose over 6% in late trading. As of press time, it was up 5.88% at HK$20.0, with a turnover of HK$191 million.
On the news front, on September 30, LYGEND RESOURCE was officially listed on the Main Board of the Shenzhen Stock Exchange, marking the completion of an "A+H" dual capital platform layout by this global leader in the nickel industry chain, and making it the first "H-to-A" listed company on the Shenzhen Main Board since the implementation of the full registration system. As of market close, N Lygend rose 206.6% to 65.09 yuan.
The prospectus shows that LYGEND RESOURCE's main business covers upstream nickel resource procurement, nickel product trading, and the production and sales of nickel products. The company started with nickel product trading and, after years of vertical integration along the industry chain, has formed an integrated business layout covering nickel product trading and the production and sales of nickel products. According to a China Insights Consultancy report, in 2024 the company ranked first globally in nickel product trading volume, equivalent to 10.4% of global nickel product market demand that year; the company is also China's largest nickel ore supplier, with a market share of approximately 35.8% that year.
Related Articles

Morgan Stanley: Maintains GEELY AUTO (00175) "Overweight" rating, target price HK$27

HK Stock Market Move | REMEGEN(09995) rose over 3% in late trading; analysis results of the Chinese Phase III clinical study of Telitacicept for the treatment of gMG were announced at the AANEM Annual Meeting.

Expectations for Stock Connect inclusion are heating up; this low-profile computing power company is worth watching.
Morgan Stanley: Maintains GEELY AUTO (00175) "Overweight" rating, target price HK$27

HK Stock Market Move | REMEGEN(09995) rose over 3% in late trading; analysis results of the Chinese Phase III clinical study of Telitacicept for the treatment of gMG were announced at the AANEM Annual Meeting.

Expectations for Stock Connect inclusion are heating up; this low-profile computing power company is worth watching.






